.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Farmers Insurance
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission
Daiichi Sankyo
Fish and Richardson
Dow
Accenture

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020725

« Back to Dashboard
NDA 020725 describes CREON, which is a drug marketed by Abbvie and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the CREON profile page.

The generic ingredient in CREON is pancrelipase (amylase;lipase;protease). There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pancrelipase (amylase;lipase;protease) profile page.

Summary for 020725

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Suppliers and Packaging for NDA: 020725

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL 020725 NDA AbbVie Inc. 0032-1203 0032-1203-64 1 BOTTLE in 1 CARTON (0032-1203-64) > 70 CAPSULE, DELAYED RELEASE in 1 BOTTLE
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL 020725 NDA AbbVie Inc. 0032-1203 0032-1203-70 1 BOTTLE in 1 CARTON (0032-1203-70) > 70 CAPSULE, DELAYED RELEASE in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED RELEASE;ORALStrength30,000USP UNITS;6,000USP UNITS;19,000USP UNITS
Approval Date:Apr 30, 2009TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 7, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED RELEASE;ORALStrength60,000USP UNITS;12,000USP UNITS;38,000USP UNITS
Approval Date:Apr 30, 2009TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 7, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED RELEASE;ORALStrength120,000USP UNITS;24,000USP UNITS;76,000USP UNITS
Approval Date:Apr 30, 2009TE:RLD:Yes
Patent:► SubscribePatent Expiration:Feb 7, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF EXOCRINE PANCREATIC INSUFFICIENCY


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Johnson and Johnson
Harvard Business School
Novartis
Deloitte
Cipla
Colorcon
US Department of Justice
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot